Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandra Mohan

Showing results (31-40 of 630) with videos related to

Pageof 63
Sort By:
Kidney International|October 6, 2024
Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohortsSonja Vodehnal, Chandra Mohan
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Three pathogenic determinants in immune nephritis--anti-glomerular antibody specificity, innate triggers and host geneticsTianfu Wu, Chandra Mohan
International Journal of Clinical Rheumatology|May 27, 2014
Systemic lupus erythematosus diagnostics in the 'omics' eraCristina Arriens, Chandra Mohan
Critical Reviews in Immunology|April 26, 2021
Immunological Biomarkers of COVID-19Rongwei Lei, Chandra Mohan
Clinical Immunology (Orlando, Fla.)|August 8, 2016
Lupus nephritis biomarkersSamar Soliman, Chandra Mohan
Frontiers in Microbiology|May 21, 2020
Regulation of Type II Toxin-Antitoxin Systems: The Translation-Responsive ModelBhaskar Chandra Mohan Ramisetty
Annals of the Rheumatic Diseases|March 23, 2025
Response to: 'CD19-CAR T-cell therapy induces deep tissue depletion of B cells' by Tur et alRahul K Patel, Chandra Mohan
Frontiers in Neurology|April 5, 2017
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal FluidRose Ann Huynh, Chandra Mohan
Applied Intelligence (Dordrecht, Netherlands)|November 12, 2021
Explainable deep neural networks for novel viral genome predictionChandra Mohan Dasari, Raju Bhukya
Expert Opinion on Therapeutic Targets|August 13, 2009
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosusBenjamin F Chong, Chandra Mohan
Pageof 63

Showing results (31-40 of 630) with videos related to

Sort By:
Pageof 63
Kidney International|October 6, 2024
Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohortsSonja Vodehnal, Chandra Mohan
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Three pathogenic determinants in immune nephritis--anti-glomerular antibody specificity, innate triggers and host geneticsTianfu Wu, Chandra Mohan
International Journal of Clinical Rheumatology|May 27, 2014
Systemic lupus erythematosus diagnostics in the 'omics' eraCristina Arriens, Chandra Mohan
Critical Reviews in Immunology|April 26, 2021
Immunological Biomarkers of COVID-19Rongwei Lei, Chandra Mohan
Clinical Immunology (Orlando, Fla.)|August 8, 2016
Lupus nephritis biomarkersSamar Soliman, Chandra Mohan
Frontiers in Microbiology|May 21, 2020
Regulation of Type II Toxin-Antitoxin Systems: The Translation-Responsive ModelBhaskar Chandra Mohan Ramisetty
Annals of the Rheumatic Diseases|March 23, 2025
Response to: 'CD19-CAR T-cell therapy induces deep tissue depletion of B cells' by Tur et alRahul K Patel, Chandra Mohan
Frontiers in Neurology|April 5, 2017
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal FluidRose Ann Huynh, Chandra Mohan
Applied Intelligence (Dordrecht, Netherlands)|November 12, 2021
Explainable deep neural networks for novel viral genome predictionChandra Mohan Dasari, Raju Bhukya
Expert Opinion on Therapeutic Targets|August 13, 2009
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosusBenjamin F Chong, Chandra Mohan
Pageof 63